Aberdeen Group plc MYGN β€” MYRIAD GENETICS INC

Ownership history in Aberdeen Group plc  Β·  4 quarters on record

AI Ownership Summary

Aberdeen Group plc reported MYRIAD GENETICS INC (MYGN) in 4 quarterly 13F filings from 2025 Q2 through 2026 Q1. Peak portfolio weight reached 0.01% in 2025 Q4. The latest visible filing shows MYGN at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this MYGN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Aberdeen Group plc's position in MYRIAD GENETICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

MYGN was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

MYGN stock page Aberdeen Group plc fund profile Aberdeen Group plc full holdings
How Aberdeen Group plc held MYGN β€” position size vs. price
% of Fund (quarterly)    MYGN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED β€” β€” β€” 1,110,404 +224,603 +25.4% 0.01% $5.0M 2026-04-29 $4.68
2025 Q4 ADDED β€” β€” β€” 885,801 +246,748 +38.6% 0.01% $5.4M 2026-01-16 $5.92
2025 Q3 ADDED β€” β€” β€” 639,053 +409,460 +178.3% 0.01% $4.6M 2025-11-07 $6.30
2025 Q2 INITIATED β€” β€” β€” 229,593 β€” β€” 0.00% $1.2M 2025-07-24 $4.65

🏒 Other funds also holding MYGN

As of 2026 Q1 β€” sorted by position size

Y-Intercept (Hong Kong) Ltd 3Y 0.06% Inspire Investing, LLC 3Y 7Y 0.04% HARBOR CAPITAL ADVISORS, INC. 3Y 0.03% Assenagon Asset Management S.A. 3Y 7Y 0.01% PROFUND ADVISORS LLC 3Y 7Y 0.01% OP Asset Management Ltd 0.01% Inscription Capital, LLC 3Y 0.01% Abacus Wealth Partners, LLC 0.01% Versant Capital Management, Inc 3Y 7Y 0.0% E Fund Management Co., Ltd. 3Y 0.0%

FAQ About Aberdeen Group plc and MYGN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Aberdeen Group plc reported owning MYGN?

Aberdeen Group plc reported MYGN across 4 quarterly 13F filings, from 2025 Q2 through 2026 Q1.

What was the largest reported MYGN position in Aberdeen Group plc's portfolio?

The largest reported portfolio weight for MYGN was 0.01% in 2025 Q4.

What is the latest reported MYGN position on this page?

The most recent filing on this page is 2026 Q1, when Aberdeen Group plc reported 1,110,404 shares, equal to 0.01% of portfolio, with an estimated market value of $5.0M.

What does the chart on this MYGN ownership page compare?

The chart compares Aberdeen Group plc's quarterly MYGN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Aberdeen Group plc time their MYGN position?

Based on 13F filing dates vs. subsequent MYGN price moves, Aberdeen Group plc correctly timed 1 out of 3 reported position changes (33%). The annualised alpha on MYGN relative to SPY over the holding period was -14.2%.

← Back to Aberdeen Group plc Holdings